Niu et al. revealed a noteworthy upregulation of ATIC in the tissues and cells of lung adenocarcinoma, and this increased expression exhibited a strong correlation with diminished survival rates and an advanced clinical stage among LUAD patients (Niu et al. 2022). This evidence concerns the gene ATIC and lung adenocarcinoma.